Detail page

Knowledge Web

Person

Annika Nelde

Name	Annika Nelde
Place	Deutschland
Gender	weiblich
Academic degree	Dr. (Universität Tübingen)
Variant	Annika Stephanie Nelde
Related	Universitätsklinikum Tübingen Eberhard Karls Universität Tübingen Biologie (Thema) Molekulare Medizin (Thema)
Record type	Person
GND-Identifier	1280834684
Record ID	1280834684
Involved in show all Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A03 and HLA-B15 via peptide-PRISM TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency Immune surveillance of acute myeloid leukemia is mediated by HLA-presented antigens on leukemia progenitor cells Immunopeptidomik - Entwicklung therapeutischer Vakzinen zur Behandlung von Leukämien The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A02:01‑restricted T cell epitopes, which are presented and recognized in vivo NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies Designing a SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groups SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition Cancer testis antigen Cyclin A1 harbors several HLA-A02:01-restricted T cell epitopes, which are presented and recognized in vivo Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling

Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling

Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A03 and HLA-B15 via peptide-PRISM

TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

Immune surveillance of acute myeloid leukemia is mediated by HLA-presented antigens on leukemia progenitor cells

Immunopeptidomik - Entwicklung therapeutischer Vakzinen zur Behandlung von Leukämien

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens

SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Designing a SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groups

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy